Auto - Parts
Compare Stocks
4 / 10Stock Comparison
SRI vs CPS vs VC vs THRM
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
Auto - Parts
Auto - Parts
SRI vs CPS vs VC vs THRM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Auto - Parts | Auto - Parts | Auto - Parts | Auto - Parts |
| Market Cap | $215M | $542M | $3.01B | $944M |
| Revenue (TTM) | $861M | $688.43B | $3.79B | $1.53B |
| Net Income (TTM) | $-103M | $-33.31B | $201M | $23M |
| Gross Margin | 20.1% | 12.0% | 13.4% | 23.6% |
| Operating Margin | -2.0% | 0.0% | 7.9% | 4.7% |
| Forward P/E | 29.3x | 10.9x | 13.1x | 11.6x |
| Total Debt | $190M | $1.26B | $540M | $295M |
| Cash & Equiv. | $66M | $198M | $771M | $161M |
SRI vs CPS vs VC vs THRM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Stoneridge, Inc. (SRI) | 100 | 37.0 | -63.0% |
| Cooper-Standard Hol… (CPS) | 100 | 290.8 | +190.8% |
| Visteon Corporation (VC) | 100 | 156.0 | +56.0% |
| Gentherm Incorporat… (THRM) | 100 | 75.7 | -24.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SRI vs CPS vs VC vs THRM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SRI is the #2 pick in this set and the best alternative if momentum is your priority.
- +73.3% vs THRM's +19.1%
CPS is the clearest fit if your priority is value.
- Lower P/E (10.9x vs 11.6x)
VC carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.14, yield 0.5%
- 52.8% 10Y total return vs THRM's -14.9%
- Lower volatility, beta 1.14, Low D/E 32.7%, current ratio 1.80x
- Beta 1.14, yield 0.5%, current ratio 1.80x
THRM is the clearest fit if your priority is growth exposure.
- Rev growth 2.6%, EPS growth -70.9%, 3Y rev CAGR 7.5%
- 2.6% revenue growth vs SRI's -5.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.6% revenue growth vs SRI's -5.2% | |
| Value | Lower P/E (10.9x vs 11.6x) | |
| Quality / Margins | 5.3% margin vs SRI's -11.9% | |
| Stability / Safety | Beta 1.14 vs SRI's 2.72, lower leverage | |
| Dividends | 0.5% yield; 2-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +73.3% vs THRM's +19.1% | |
| Efficiency (ROA) | 6.1% ROA vs SRI's -16.6%, ROIC 19.5% vs -3.7% |
SRI vs CPS vs VC vs THRM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SRI vs CPS vs VC vs THRM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VC leads in 4 of 6 categories
CPS leads 1 • SRI leads 0 • THRM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CPS is the larger business by revenue, generating $688.4B annually — 799.3x SRI's $861M. VC is the more profitable business, keeping 5.3% of every revenue dollar as net income compared to SRI's -11.9%. On growth, CPS holds the edge at +1027.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $861M | $688.4B | $3.8B | $1.5B |
| EBITDAEarnings before interest/tax | $17M | $210M | $382M | $127M |
| Net IncomeAfter-tax profit | -$103M | -$33.3B | $201M | $23M |
| Free Cash FlowCash after capex | $12M | -$93.1B | $305M | $79M |
| Gross MarginGross profit ÷ Revenue | +20.1% | +12.0% | +13.4% | +23.6% |
| Operating MarginEBIT ÷ Revenue | -2.0% | +0.0% | +7.9% | +4.7% |
| Net MarginNet income ÷ Revenue | -11.9% | -4.8% | +5.3% | +1.5% |
| FCF MarginFCF ÷ Revenue | +1.4% | -13.5% | +8.1% | +5.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.0% | +1027.9% | +2.1% | +11.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -11.5% | -22.4% | -0.4% | — |
Valuation Metrics
CPS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 15.4x trailing earnings, VC trades at a 70% valuation discount to THRM's 51.4x P/E. On an enterprise value basis, VC's 6.3x EV/EBITDA is more attractive than SRI's 20.3x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $215M | $542M | $3.0B | $944M |
| Enterprise ValueMkt cap + debt − cash | $339M | $1.6B | $2.8B | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | -2.06x | -132.65x | 15.43x | 51.35x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.27x | 10.88x | 13.12x | 11.57x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 20.26x | 7.84x | 6.34x | 8.21x |
| Price / SalesMarket cap ÷ Revenue | 0.25x | 0.20x | 0.80x | 0.63x |
| Price / BookPrice ÷ Book value/share | 1.18x | — | 1.88x | 1.32x |
| Price / FCFMarket cap ÷ FCF | 17.65x | 33.34x | 10.88x | 15.45x |
Profitability & Efficiency
VC leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
VC delivers a 12.7% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-44 for SRI. VC carries lower financial leverage with a 0.33x debt-to-equity ratio, signaling a more conservative balance sheet compared to SRI's 1.06x. On the Piotroski fundamental quality scale (0–9), VC scores 6/9 vs SRI's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -43.5% | — | +12.7% | +3.2% |
| ROA (TTM)Return on assets | -16.6% | -7.2% | +6.1% | +1.6% |
| ROICReturn on invested capital | -3.7% | +8.6% | +19.5% | +7.3% |
| ROCEReturn on capital employed | -3.9% | +9.2% | +15.2% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.06x | — | 0.33x | 0.41x |
| Net DebtTotal debt minus cash | $124M | $1.1B | -$231M | $134M |
| Cash & Equiv.Liquid assets | $66M | $198M | $771M | $161M |
| Total DebtShort + long-term debt | $190M | $1.3B | $540M | $295M |
| Interest CoverageEBIT ÷ Interest expense | -1.25x | 0.91x | 124.00x | 5.83x |
Total Returns (Dividends Reinvested)
Evenly matched — SRI and CPS and VC each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VC five years ago would be worth $8,912 today (with dividends reinvested), compared to $2,233 for SRI. Over the past 12 months, SRI leads with a +73.3% total return vs THRM's +19.1%. The 3-year compound annual growth rate (CAGR) favors CPS at 38.4% vs SRI's -22.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +27.5% | -6.4% | +16.4% | -16.3% |
| 1-Year ReturnPast 12 months | +73.3% | +21.6% | +40.3% | +19.1% |
| 3-Year ReturnCumulative with dividends | -53.6% | +165.3% | -17.2% | -48.0% |
| 5-Year ReturnCumulative with dividends | -77.7% | -12.5% | -10.9% | -58.0% |
| 10-Year ReturnCumulative with dividends | -46.0% | -63.7% | +52.8% | -14.9% |
| CAGR (3Y)Annualised 3-year return | -22.6% | +38.4% | -6.1% | -19.6% |
Risk & Volatility
VC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VC is the less volatile stock with a 1.14 beta — it tends to amplify market swings less than SRI's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VC currently trades 87.0% from its 52-week high vs CPS's 63.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.72x | 1.52x | 1.14x | 1.43x |
| 52-Week HighHighest price in past year | $9.71 | $47.77 | $129.10 | $39.48 |
| 52-Week LowLowest price in past year | $4.24 | $19.32 | $80.08 | $25.47 |
| % of 52W HighCurrent price vs 52-week peak | +78.4% | +63.9% | +87.0% | +78.0% |
| RSI (14)Momentum oscillator 0–100 | 60.5 | 51.1 | 67.6 | 59.7 |
| Avg Volume (50D)Average daily shares traded | 235K | 198K | 601K | 239K |
Analyst Outlook
VC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: SRI as "Buy", CPS as "Hold", VC as "Buy", THRM as "Buy". Consensus price targets imply 80.3% upside for CPS (target: $55) vs 7.7% for VC (target: $121). VC is the only dividend payer here at 0.48% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $55.00 | $121.00 | $36.67 |
| # AnalystsCovering analysts | 9 | 10 | 23 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.5% | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | 2 | 0 |
| Dividend / ShareAnnual DPS | — | — | $0.54 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +1.9% | +1.1% |
VC leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CPS leads in 1 (Valuation Metrics). 1 tied.
SRI vs CPS vs VC vs THRM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SRI or CPS or VC or THRM a better buy right now?
For growth investors, Gentherm Incorporated (THRM) is the stronger pick with 2.
6% revenue growth year-over-year, versus -5. 2% for Stoneridge, Inc. (SRI). Visteon Corporation (VC) offers the better valuation at 15. 4x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate Stoneridge, Inc. (SRI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SRI or CPS or VC or THRM?
On trailing P/E, Visteon Corporation (VC) is the cheapest at 15.
4x versus Gentherm Incorporated at 51. 4x. On forward P/E, Cooper-Standard Holdings Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SRI or CPS or VC or THRM?
Over the past 5 years, Visteon Corporation (VC) delivered a total return of -10.
9%, compared to -77. 7% for Stoneridge, Inc. (SRI). Over 10 years, the gap is even starker: VC returned +52. 8% versus CPS's -63. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SRI or CPS or VC or THRM?
By beta (market sensitivity over 5 years), Visteon Corporation (VC) is the lower-risk stock at 1.
14β versus Stoneridge, Inc. 's 2. 72β — meaning SRI is approximately 139% more volatile than VC relative to the S&P 500. On balance sheet safety, Visteon Corporation (VC) carries a lower debt/equity ratio of 33% versus 106% for Stoneridge, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SRI or CPS or VC or THRM?
By revenue growth (latest reported year), Gentherm Incorporated (THRM) is pulling ahead at 2.
6% versus -5. 2% for Stoneridge, Inc. (SRI). On earnings-per-share growth, the picture is similar: Cooper-Standard Holdings Inc. grew EPS 94. 9% year-over-year, compared to -516. 7% for Stoneridge, Inc.. Over a 3-year CAGR, THRM leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SRI or CPS or VC or THRM?
Visteon Corporation (VC) is the more profitable company, earning 5.
3% net margin versus -11. 9% for Stoneridge, Inc. — meaning it keeps 5. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VC leads at 8. 8% versus -2. 0% for SRI. At the gross margin level — before operating expenses — THRM leads at 23. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SRI or CPS or VC or THRM more undervalued right now?
On forward earnings alone, Cooper-Standard Holdings Inc.
(CPS) trades at 10. 9x forward P/E versus 29. 3x for Stoneridge, Inc. — 18. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CPS: 80. 3% to $55. 00.
08Which pays a better dividend — SRI or CPS or VC or THRM?
In this comparison, VC (0.
5% yield) pays a dividend. SRI, CPS, THRM do not pay a meaningful dividend and should not be held primarily for income.
09Is SRI or CPS or VC or THRM better for a retirement portfolio?
For long-horizon retirement investors, Visteon Corporation (VC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
14)). Stoneridge, Inc. (SRI) carries a higher beta of 2. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VC: +52. 8%, SRI: -46. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SRI and CPS and VC and THRM?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SRI is a small-cap quality compounder stock; CPS is a small-cap quality compounder stock; VC is a small-cap deep-value stock; THRM is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.